LDL-Apheresis: Technical and Clinical Aspects

LDL-Apheresis: Technical and Clinical Aspects

The prognosis of patients suffering from severe hyperlipidemia, sometimes combined with elevated lipoprotein (a) levels, and coronary heart disease refractory to diet and lipid-lowering drugs is poor. For such patients, regular treatment with low-density lipoprotein (LDL) apheresis is the therapeuti...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rolf Bambauer, Carolin Bambauer, Boris Lehmann, Reinhard Latza, Ralf Schiel
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Series:	The Scientific World Journal
Online Access:	http://dx.doi.org/10.1100/2012/314283
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Surface-Treated versus Untreated Large-Bore Catheters as Vascular Access in Hemodialysis and Apheresis Treatments
by: Rolf Bambauer, et al.
Published: (2012-01-01)

How can destination management organisations enhance their social media marketing communication in the field of sports tourism?
by: Silke Bambauer-Sachse, et al.
Published: (2025-07-01)

CLINICAL APPLICATION OF HELP-APHERESIS IN FEMALE PATIENT WITH FAMILIAL HYPERCHOLESTEROLEMIA
by: OLGA L. Barbarash, et al.
Published: (2018-12-01)

Oxidized LDL and LOX-1 in Experimental Sepsis
by: Nadia Al-Banna, et al.
Published: (2013-01-01)

LIPOPROTEIN APHERESIS: YESTERDAY, TODAY, TOMORROW. REVIEW
by: U. Julius, et al.
Published: (2018-09-01)

Comparison of harvesting methods and clinical application of apheresis platelet concentrates with additive solution
by: O. V. Karpova, et al.
Published: (2015-06-01)

Therapeutic Apheresis in Glomerular Diseases after Kidney Transplantation
by: Maurizio Salvadori, et al.
Published: (2020-05-01)

Estimation of serum calcium levels in apheresis platelet donors
by: P. Arpitha, et al.
Published: (2024-01-01)

The impact of pathogen reduction on ABO isoagglutinin titers in apheresis platelets
by: Mikayel Yeghiazaryan, et al.
Published: (2025-07-01)

Label‐Free Microfluidic Apheresis of Circulating Tumor Cell Clusters
by: Li Zhan, et al.
Published: (2024-10-01)

Application and clinical efficacy of red blood cell therapeutic apheresis in erythropoietic protoporphyria and hereditary hemochromatosis
by: LIU Haoqiang, et al.
Published: (2025-07-01)

WCN24-1516 THERAPEUTIC APHERESIS IN KIDNEY TRANSPLANTATION; EMERGING TRENDS
by: Chimezie Okwuonu, et al.
Published: (2024-04-01)

Bacterial contamination of platelets apheresis: a single-center retrospective analysis
by: LUO Yuanyuan, et al.
Published: (2025-02-01)

Is it possible to regress atherosclerotic lesions with long-term treatment with lipoprotein apheresis?
by: Ulrich Julius, et al.
Published: (2024-10-01)

LDL estimation with equations and machine learning; variance of LDL and plasma atherogenic index
by: Petros Paplomatas, et al.
Published: (2024-12-01)

Research the effect of 4℃ refrigerated stored apheresis platelets based on platelet metabolomics
by: XIA Xiaoye, et al.
Published: (2025-04-01)

THERAPEUTIC APHERESIS FOR EPIDERMOLYSIS BULLOSA AND SECONDARY THROMBOCYTOSIS IN NORWEGIAN SCABIES: A CASE REPORT
by: Mine Ezgi Payaslı, et al.
Published: (2025-07-01)

European survey on CAR T-Cell analytical methods from apheresis to post-infusion immunomonitoring
by: Biagio De Angelis, et al.
Published: (2025-04-01)

Preparation of Plasma-based Medicinal Products in Combating Coagulation Factors Deficiencies by Apheresis Technique
by: Dunya, Y.*, Bukar, A., Obi, S.O., Medugu, J.T., Waziri, N.S., John, W.K., Mela, T.S., Halima, I., Azuike, C.G.
Published: (2025-05-01)

Effect of Apheresis for ABO and HLA Desensitization on Anti-Measles Antibody Titers in Renal Transplantation
by: Ulf Schönermarck, et al.
Published: (2011-01-01)

Apheresis Therapy for Steroid-Resistant Idiopathic Nephrotic Syndrome: Report on a Case Series
by: Hamza Naciri Bennani, et al.
Published: (2019-01-01)

Evaluation of the safety and efficacy of ABO non-identical apheresis platelets with reduced plasma transfusion
by: DIAO Ronghua, et al.
Published: (2025-07-01)

Effects of Alirocumab and Evolocumab on Cardiovascular Mortality and LDL-C: Stratified According to the Baseline LDL-C Levels
by: Hui Ma, et al.
Published: (2025-04-01)

Author reply to technical comment on: Rachamin et al. Statin treatment and LDL target value achievement in Swiss general practice
by: Yael Rachamin, et al.
Published: (2020-11-01)

Association of sdLDL-C/LDL-C ratio with atherosclerotic cardiovascular disease: a case-control study
by: Yuxin Yang, et al.
Published: (2025-06-01)

Platelet apheresis with additive solution and plasma rinseback affects the cellular composition of LRS chamber products
by: Katharina Kronenberg, et al.
Published: (2025-06-01)

Evaluation of ultrasonography and plethysmography in detecting blood loss and volume replacement in a platelet apheresis model
by: Kıvanç KARAMAN, et al.
Published: (2025-01-01)

Application of mass cytometry to characterize hematopoietic stem cells in apheresis products of patients with hematological malignancies
by: Carlos Agustin Villegas-Valverde, et al.
Published: (2024-12-01)

Beyond LDL-C: discordant small dense LDL cholesterol stratifies hypertension risk in a Chinese longitudinal cohort
by: Xiaofei Wu, et al.
Published: (2025-06-01)

oxLDL Downregulates the Dendritic Cell Homing Factors CCR7 and CCL21
by: Thomas Nickel, et al.
Published: (2012-01-01)

Oxidized LDL and Risk of Coronary Heart Disease
by: Luma Abdalmunim Baker
Published: (2023-01-01)

Therapeutic plasma exchange using apheresis: Clinical experience and outcomes in neurological and non-neurological cases at a tertiary care center in western India
by: Shashikant Baraku Patil, et al.
Published: (2025-07-01)

Technical aspects of Verrocchio's Candelabrum
by: F. Scholten
Published: (1996-06-01)

TECHNICAL ASPECTS OF JEWELRY DESIGN
by: V. P. Lugovoy
Published: (2011-08-01)

Dynamic changes of iron metabolism and the effectiveness of health education among apheresis donors in Guangzhou under the GLMM framework
by: CHEN Xiaowen, et al.
Published: (2025-06-01)

OxLDL plasma levels in patients with Alzheimer's disease
by: Marina Felipe Grossi, et al.

Natural Polyamine Spermidine Inhibits the In Vitro Oxidation of LDL
by: Christine Rossmann, et al.
Published: (2025-02-01)

A potential marker for increased LDL and hypertriglyceridemia risk
by: K.I.S.N. VAISHNAVI, et al.
Published: (2024-09-01)

Implication of Low HDL-c Levels in Patients with Average LDL-c Levels: A Focus on Oxidized LDL, Large HDL Subpopulation, and Adiponectin
by: Filipa Mascarenhas-Melo, et al.
Published: (2013-01-01)

A Prospective Study of Adverse Events in Whole Blood and Apheresis Donors at a Tertiary Care Hospital in Western India
by: Mamta Shah, et al.
Published: (2024-11-01)